Acetoxymethyl 5-((3-(4-cyclopropyl-1,2,3,4-tetrahydroquinoxaline-1-carbonyl)pyridin-4-yl)oxy)benzofuran-3-carboxylate

ID: ALA4782069

Chembl Id: CHEMBL4782069

PubChem CID: 156705115

Max Phase: Preclinical

Molecular Formula: C29H25N3O7

Molecular Weight: 527.53

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)OCOC(=O)c1coc2ccc(Oc3ccncc3C(=O)N3CCN(C4CC4)c4ccccc43)cc12

Standard InChI:  InChI=1S/C29H25N3O7/c1-18(33)37-17-38-29(35)23-16-36-26-9-8-20(14-21(23)26)39-27-10-11-30-15-22(27)28(34)32-13-12-31(19-6-7-19)24-4-2-3-5-25(24)32/h2-5,8-11,14-16,19H,6-7,12-13,17H2,1H3

Standard InChI Key:  AEQZAQRSTOVCGZ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4782069

    ---

Associated Targets(Human)

GPBAR1 Tchem G-protein coupled bile acid receptor 1 (1723 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Gpbar1 G-protein coupled bile acid receptor 1 (577 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 527.53Molecular Weight (Monoisotopic): 527.1693AlogP: 4.93#Rotatable Bonds: 7
Polar Surface Area: 111.41Molecular Species: NEUTRALHBA: 9HBD:
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.59CX LogP: 3.64CX LogD: 3.64
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.24Np Likeness Score: -0.41

References

1. Han F,Ning M,Cao H,Ye Y,Feng Y,Leng Y,Shen J.  (2020)  Design of G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) soft drugs with reduced gallbladder-filling effects.,  203  [PMID:32682201] [10.1016/j.ejmech.2020.112619]

Source